Lenalidomide 10mg capsules
NHS hospitals in England used £229,727,025 of indicative cost of Lenalidomide 10mg capsules in the 12 months to April 2026, about 0.9% of all hospital medicines spend. That is up 20.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenalidomide 10mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenalidomide 10mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £5,916,600 |
| Univ Hpl B/Ham Nhs Foundation Trust | £5,388,660 |
| Colchester Hospital University Nhs Ft | £4,888,980 |
| University College London Foundation Tr | £4,724,145 |
| Southend Univ Hosp Nhs Foundation Trust | £4,096,260 |
| Derby Teaching Hospitals Nhs Found Trust | £3,900,420 |
| University Hpls Of Leicester Nhs Trust | £3,640,320 |
| United Lincolnshire Hospitals Nhs Trust | £3,554,100 |
| Gloucestershire Hpls Nhs Foundation Trst | £3,486,780 |
| East Kent Hospitals University Nhs Ft | £3,449,880 |
The primary-care picture
Lenalidomide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenalidomide medicine page.